Internal Medicine, Cardiovascular Disease · Mendham, NJ
NPI
1699751388
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
8 Tempe Wick Rd
Mendham, NJ, 07945
Phone (973) 543-2288
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
4,497 services
Medicare patients, 2024
1,540
Average age 77
Drug cost, 2024
$1.8M
10,559 prescriptions
Company payments, 2025
$39.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas P Ricculli was code 99213 (office e&m - established), 1,186 times for 791 patients. In total Nicholas P Ricculli billed 4,497 services in 33 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,186 | 791 | $66.13 | $78K |
| 99214 Office E&M - Established | Office | 894 | 555 | $99.20 | $89K |
| 93000 Electrocardiogram | Office | 742 | 628 | $10.84 | $8,046 |
| 93010 Electrocardiogram | Facility | 562 | 473 | $6.80 | $3,821 |
| 36415 Venipuncture Blood Collection | Office | 279 | 186 | $8.65 | $2,413 |
| 93306 Echocardiography (TTE/TEE) | Office | 226 | 221 | $68.05 | $15K |
| 93016 Electrocardiogram | Office | 116 | 113 | $16.27 | $1,887 |
| 93018 Electrocardiogram | Office | 113 | 110 | $10.88 | $1,229 |
| 99215 Office E&M - Established | Office | 54 | 48 | $150.98 | $8,153 |
| 99204 Office E&M - New | Office | 47 | 47 | $128.06 | $6,019 |
| 93248 Electrocardiogram | Office | 46 | 42 | $21.25 | $978 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 46 | 46 | $37.37 | $1,719 |
| 93246 Electrocardiogram | Office | 40 | 38 | $10.87 | $435 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 19 | $97.81 | $2,934 |
| 93306 Echocardiography (TTE/TEE) | Facility | 20 | 20 | $57.35 | $1,147 |
By year: 2022 $236K for 4,783 services; 2023 $231K for 4,560 services; 2024 $226K for 4,497 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 279 | 186 | $8.65 | $2,413 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas P Ricculli prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,094 prescriptions and refills. In total Nicholas P Ricculli wrote 10,559 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,094 | 3,178 | 328 | $12K |
| Amlodipine Besylate Generic | 937 | 2,681 | 283 | $7,297 |
| Metoprolol Succinate Generic | 853 | 2,430 | 249 | $16K |
| Rosuvastatin Calcium Generic | 701 | 2,006 | 227 | $10K |
| Xarelto Rivaroxaban | 528 | 1,248 | 133 | $668K |
| Eliquis Apixaban | 487 | 1,033 | 134 | $578K |
| Losartan Potassium Generic | 311 | 917 | 99 | $4,419 |
| Lisinopril Generic | 261 | 729 | 73 | $2,056 |
| Ezetimibe Generic | 222 | 657 | 71 | $4,998 |
| Hydrochlorothiazide Generic | 199 | 566 | 68 | $917 |
| Metoprolol Tartrate Generic | 196 | 515 | 56 | $1,972 |
| Clopidogrel Clopidogrel Bisulfate | 192 | 548 | 68 | $3,238 |
| Carvedilol Generic | 184 | 506 | 51 | $2,518 |
| Valsartan Generic | 179 | 529 | 57 | $6,544 |
| Chlorthalidone Generic | 158 | 445 | 48 | $3,240 |
Brand drugs: 1,462 claims; generic drugs: 9,097 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas P Ricculli $39.8 ($39.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $39.8.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 2 | $39.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.